Call for Papers   a href="https://bentham.manuscriptpoint.com/journals/acamc" class="submit_manuscript">Call for Papers  

Article Details

Tisotumab Vedotin: The First FDA-Approved Antibody-Drug Conjugate for Cervical Cancer

[ Vol. 22 , Issue. 16 ]

Author(s):

Surya K. De*   Pages 2808 - 2810 ( 3 )

Abstract:


Keywords:

Affiliation:



Read Full-Text article